Angelini Ventures
Life-sciences and health innovation investor (Angelini Group)
VC
Sector Specialist
📍 Rome, Italy
AUM
Not Disclosed
Strategic / Balance-Sheet
PRIVATE
Angelini Ventures invests in life-sciences and health innovation companies. Aptadir Therapeutics’ September 2026 seed round press release names Angelini Ventures among participants, including via the EXTEND initiative.
Investment Focus
Stages
Seed · Series A · Series B
Sectors
Biotech · Life Sciences · Healthtech
VCLife SciencesItalyDaily Discovery
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of recent date. Refreshed periodically.